SCHEMBL216179

SCHEMBL216179

CNc1c[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.54
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
GPR84 Q9NQS5 3/20 0.52
MAPT P10636 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
CYP3A4 P08684 2/20 0.52
AHR P35869 1/20 0.52
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HTR1A P08908 1/20 0.50
HTR2A P28223 1/20 0.50
HTT P42858 1/20 0.50
STING1 Q86WV6 7/20 0.49
NR4A2 P43354 1/20 0.46
CREBBP Q92793 1/20 0.46
FFAR1 O14842 1/20 0.46
PBRM1 Q86U86 1/20 0.46
THRB P10828 1/20 0.45
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL4500293 0.89 STING1 (0.52) ATMMEN1KMT2AGPR84MAPT
SCHEMBL6654114 0.82 ATM (0.52) ATMMEN1KMT2AGPR84MAPT
SCHEMBL28420595 0.78 ATM (0.48) ATMMEN1KMT2AGPR84MAPT
SCHEMBL28346693 0.78 STING1 (0.49) ATMMEN1KMT2AGPR84MAPT
SCHEMBL1898356 0.78 ATM (0.48) ATMMEN1KMT2AGPR84MAPT
SCHEMBL9011712 0.78 STING1 (0.49) ATMMEN1KMT2AGPR84MAPT
SCHEMBL22328234 0.78 ATM (0.48) ATMMEN1KMT2AGPR84MAPT
SCHEMBL30753171 0.78 HTR2A (0.51) ATMMEN1KMT2AGPR84MAPT
SCHEMBL1260955 0.78 HTR2A (0.51) ATMMEN1KMT2AGPR84MAPT
SCHEMBL25571556 0.78 GPR84 (0.50) ATMMEN1KMT2AGPR84MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118908874-A PAD4 inhibitor, preparation method thereof and application thereof in preparation of anti-pulmonary fibrosis drugs 首都医科大学 2024-11-08 CN claimed
CN-116133442-A Perovskite solar cell based on organic molecule modified lithium salt doped hole transport layer 陕西师范大学 2023-05-16 CN claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
CN-108892634-A A kind of indole methyl amino benzenes compounds and its application 浙江工业大学 2018-11-27 CN claimed
CN-104530013-B Pyrazol acid amide compounds based on indole ring as disinfectant use in agriculture purposes 中国农业大学 2016-06-29 CN claimed
CN-104530013-A Application of indole ring-based pyrazole amide compound used as agricultural fungicide UNIV CHINA AGRICULTURAL 2015-04-22 CN claimed
CN-103261156-A New compounds for the treatment of neurodegenerative diseases LEUVEN K U RES & DEV 2013-08-21 CN claimed
US-20090028796-A1 PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) 2009-01-29 US claimed
EP-1978805-A1 PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2008-10-15 EP claimed
WO-2007085660-A1 PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2007-08-02 WO claimed
EP-0552489-B1 Peptide, production and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-03-04 EP claimed
US-5614497-A TREATMENT OF HYPERTENSION, CARDIOVASCULAR DISEASE AND RENAL DISEASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-03-25 US claimed
EP-0552489-A2 Peptide, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-07-28 EP claimed
EP-0037271-B1 INDOLE DERIVATIVES AND PROCESS FOR PREPARING THE SAME TORAY INDUSTRIES, INC. (JP) 1984-01-18 EP claimed
JP-53009763-A None JP disclosed
CN-116133442-B Perovskite solar cell based on organic molecule modified lithium salt doped hole transport layer SHAANXI NORMAL UNIVERSITY (CN) 2026-05-26 CN disclosed
CN-118908874-A PAD4 inhibitor, preparation method thereof and application thereof in preparation of anti-pulmonary fibrosis drugs 首都医科大学 2024-11-08 CN disclosed
WO-2000042213-A1 A NOVEL METHOD FOR DESIGNING PROTEIN KINASE INHIBITORS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2000-07-20 WO disclosed
CN-1109780-A Sustained-release preparation of anti-endothelin substance TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-10-11 CN disclosed
JP-S539763-A METHYLIDENE-AMINE DERIVATIVES HODOGAYA CHEM CO LTD 1978-01-28 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090028796-A1 PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES IDO1, IDO2, INMT ATM 4657/4885MEN1 3306/4885KMT2A 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.